Seelos Therapeutics Inc (SEEL)

[food4thought]

Not being a Basher as I hold a small amount but....

That comment refers to early stage clinical design development. Constant expense with no earnings until drugs come to market draws no comparison to an established big pharma.

Once clinical study data begins to show positive result, then this thing will go bananas. Unfortunately, until then, I feel it’s the same biotech dilemma. Raise cash thru dilution and reverse splits. I’ve lost way too much in small cap biotech to think this will be any different for months to come. Earnings will mean nothing to the SP. They lose money, as does most companies in this space, at least until drugs pass thru the FDA or they get bought out at a major premium. It’s the nature of the beast.

Huge money can be made but only a very small percentage ever get near the hurdle to seek approval by the FDA. I had one that looked like a slam dunk until the FDA reared it’s ugly head. My 425k got turned into 6k almost overnight. I was all in and lost everything. This can be a good flip candidate, but until things progress clinically, I can’t see a major upside without simply being a P&D candidate. Good luck.